Business Wire

Kairon Labs and Solidus Labs Partner to Redefine Ethical Market Making Under MiCA

12.12.2024 15:00:00 CET | Business Wire | Press release

Share

Kairon Labs, a leading crypto market maker and liquidity provider, has partnered with Solidus Labs, a pioneer in crypto-native compliance and risk management solutions, to strengthen its compliance program and ensure readiness for the European Union's upcoming Markets in Crypto-Assets Regulation (MiCA).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212677489/en/

Solidus Labs enters partnership with Kairon Labs (Graphic: Business Wire)

With a proven track record of supporting over 500 digital asset issuers across more than 100 exchanges, Kairon Labs is committed to ethical market-making practices that promote transparency and fairness in the crypto space. By integrating Solidus Labs' trade surveillance technology, Kairon Labs aims to proactively monitor and mitigate market manipulation risks across its operations, reinforcing its dedication to market integrity.

"As regulatory environments become increasingly stringent, it's imperative to uphold the highest standards of compliance," said Jens Willemen, Co-Founder and CEO of Kairon Labs. "Solidus Labs has proven to be the ideal partner for us, thanks to their unmatched expertise in trade surveillance and profound comprehension of the cryptocurrency landscape, especially in the context of the Markets in Crypto-Assets (MiCA) regulation. Their advanced detection algorithms, combined with a holistic compliance platform, align seamlessly with our vision of ensuring a secure trading environment for our clients while maintaining market integrity at every level."

Solidus Labs, a trusted partner for institutions dedicated to crypto integrity, provides Kairon Labs with a robust market integrity toolkit. From real-time anomaly detection to precision-driven behavioral insights, this collaboration will enable thorough monitoring and effective detection of suspicious activities across Kairon’s operations.

"By championing transparency, innovation, and trust, Kairon Labs is shaping the future—one where markets aren’t just made—they’re made better," said Asaf Meir, CEO and Founder of Solidus Labs. "With Solidus, they’re not just prepared for MiCA—they’re setting the gold standard for safe, forward-looking market making. Together, we’re building the foundation for the financial markets of tomorrow."

With MiCA’s sweeping anti-market abuse mandates set to take effect on December 30, 2024, the timing of this collaboration couldn’t be more pivotal. Kairon Labs is demonstrating that in market making, liquidity flows to safety and that market integrity is not just a responsibility—it’s a competitive advantage.

About Kairon Labs:

Kairon Labs is a premier crypto market maker and liquidity provider, offering bespoke algorithmic trading solutions to digital asset issuers. With a focus on ethical market-making practices, Kairon Labs has supported over 500 clients, ensuring successful token launches and sustained market stability. For more information, visit: Kairon Labs

About Solidus Labs

Solidus Labs is the category-definer for crypto-native security and compliance solutions: trade surveillance, transaction monitoring, and staking guard. Solidus Labs leads initiatives like the Crypto Market Integrity Coalition and the DACOM Summit, with a commitment to safe crypto trading across centralized and decentralized markets. For more information, visit: https://soliduslabs.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20241212677489/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 10:00:00 CET | Press release

Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living

Swiss Leader Leonteq Chooses ActiveViam to Deliver High‑Performance FRTB Risk Analytics10.2.2026 09:00:00 CET | Press release

ActiveViam, a global leader in real‑time, multidimensional risk analytics for capital markets, today announced that Leonteq, one of the leading Swiss providers of structured products, has implemented Atoti to calculate Market Risk Capital Charges under the Standardized Approach of the Fundamental Review of the Trading Book (SA-FRTB). ActiveViam’s flagship product, Atoti, is being used by Leonteq as its FRTB reporting solution to the Swiss Financial Market Supervisory Authority (FINMA). Switzerland implemented FRTB for its banks on 1st January 2025 and FINMA recently extended its scope to include Leonteq. When the FRTB implementation deadlines became clear, Leonteq evaluated several vendors for a solution that could integrate with its existing pricing engines. After a detailed assessment, it selected Atoti. The solution provides dashboards and preconfigured reports that meet FINMA’s requirements, along with analytics aligned to the ISDA Unit Tests and additional capabilities such as wha

Bending Spoons offers €1.5 million in tech scholarships through new Fellowship program10.2.2026 09:00:00 CET | Press release

Today Bending Spoons announced the launch of the Bending Spoons Fellowship, committing up to €1.5 million to support Europe’s most outstanding computer science students through the program. The fellowship will award ten scholarships—each worth €50,000 per year and renewable for up to three years—to high-achieving university students in computer science and related fields across Europe and the UK. “We think exceptional talent deserves exceptional opportunities,” said Costanza Mazzei, the Bending Spoons talent manager leading the program. “With the Bending Spoons Fellowship, we aim to give Europe’s most driven students the freedom, resources, and guidance to reach the highest levels of excellence.” In addition to financial support, Fellowship participants will benefit from individual mentorship and may choose to participate in an optional paid summer internship at Bending Spoons. The fellowship is the latest initiative from Bending Spoons to support emerging technical talent. It builds o

Ralph Haupter Joins Warburg Pincus as an External Senior Advisor10.2.2026 09:00:00 CET | Press release

Seasoned Technology Executive to Support European Technology Group Warburg Pincus, the pioneer of private equity global growth investing, today announced that Ralph Haupter will serve as an External Senior Advisor to its European Technology team. Mr. Haupter, Executive Vice President and Chief Revenue Officer for Small Medium Enterprises and Channel (SME&C) at Microsoft, will take on this personal engagement to help the firm identify and evaluate new investment opportunities across the software and technology sectors. He will also play an active role in value creation across the firm’s existing portfolio. Mr. Haupter brings over 25 years of global operating experience and deep expertise in technology innovation and transformation. At Microsoft, he leads a global organization that works with the company’s extensive partner ecosystem to empower small and medium businesses worldwide. Previously, he held senior leadership roles across Europe, Asia, and the Americas, including President of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye